Literature DB >> 8440073

Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients.

R P McCabe1, H Secrist, M Botney, M Egan, M G Peters.   

Abstract

Cytokines are involved in the regulation of normal immune events and may be important in the development or perpetuation of immune events in inflammatory bowel disease. We have previously shown that normal human mononuclear cells from tonsil, spleen, and peripheral blood exhibit tissue and stimulus-specific patterns of cytokine mRNA expression. The aim of this study was to determine if disease-dependent differences of cytokine mRNA expression could be found in the intestine. Total RNA was isolated from intestinal mucosa and lamina propria mononuclear cells from inflammatory bowel disease patients and controls. cDNA probes specific for interleukins (IL)-1, -4, -5, and -6 and transforming growth factor-beta were used. IL-1 beta mRNA and TGF-beta mRNA steady state expressions were higher in inflammatory bowel disease specimens than in normal intestine. In addition, mononuclear cell specimens had stronger cytokine mRNA expression than mucosal specimens. The steady state mRNA expression of proinflammatory cytokines is higher in inflammatory bowel disease, consistent with the ongoing inflammation seen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440073     DOI: 10.1006/clin.1993.1007

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  27 in total

1.  Paradoxically increased FOXP3+ T cells in IBD do not preferentially express the isoform of FOXP3 lacking exon 2.

Authors:  James D Lord; Karine Valliant-Saunders; Hejin Hahn; Richard C Thirlby; Steven F Ziegler
Journal:  Dig Dis Sci       Date:  2012-06-27       Impact factor: 3.199

2.  Polymerase chain reaction analysis of TNF-alpha and IL-6 mRNA levels in whole blood from cattle naturally or experimentally infected with Mycobacterium paratuberculosis.

Authors:  J L Adams; M T Collins; C J Czuprynski
Journal:  Can J Vet Res       Date:  1996-10       Impact factor: 1.310

3.  Transforming growth factor-betas and their signaling receptors are coexpressed in Crohn's disease.

Authors:  F F di Mola; H Friess; A Scheuren; P Di Sebastiano; H Graber; B Egger; A Zimmermann; M Korc; M W Büchler
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

4.  Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.

Authors:  I B Autenrieth; N Bucheler; E Bohn; G Heinze; I Horak
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

Review 5.  TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota.

Authors:  Sozaburo Ihara; Yoshihiro Hirata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2017-05-22       Impact factor: 7.527

6.  Cytokine-stimulated release of decay-accelerating factor (DAF;CD55) from HT-29 human intestinal epithelial cells.

Authors:  J Nasu; M Mizuno; T Uesu; K Takeuchi; T Inaba; S Ohya; M Kawada; K Shimo; H Okada; T Fujita; T Tsuji
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

7.  Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Authors:  R Raqib; A A Lindberg; B Wretlind; P K Bardhan; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  A synergistic relationship between TNF-alpha, IL-1 beta, and TGF-beta 1 on IL-6 secretion by the IEC-6 intestinal epithelial cell line.

Authors:  D W McGee; T Bamberg; S J Vitkus; J R McGhee
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

9.  Cytokine messenger RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease.

Authors:  F Autschbach; G Schürmann; L Qiao; H Merz; R Wallich; S C Meuer
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Enhanced expression of transcription factor GATA-4 in inflammatory bowel disease and its possible regulation by TGF-beta1.

Authors:  Hanna Haveri; Merja Ashorn; Sari Iltanen; David B Wilson; Leif C Andersson; Markku Heikinheimo
Journal:  J Clin Immunol       Date:  2009-04-08       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.